论文部分内容阅读
[目的]探讨门冬氨酸鸟氨酸联合醒脑静治疗肝性脑病患者的临床疗效。[方法]38例肝性脑病患者随机分成2组,治疗组20例在常规综合治疗的基础上给予门冬氨酸鸟氨酸联合醒脑静治疗,对照组18例在常规综合治疗的基础上给予谷氨酸盐治疗。观察2组患者的临床表现和血氨变化。[结果]治疗组患者血氨的降低较对照组明显(P<0.05),显效率及总有效率均明显高于对照组(P<0.05)。[结论]门冬氨酸鸟氨酸联合醒脑静治疗肝性脑病效果显著。
[Objective] To investigate the clinical efficacy of ornithine combined with xingnaojing on patients with hepatic encephalopathy. [Method] Thirty-eight patients with hepatic encephalopathy were randomly divided into 2 groups. The treatment group was given either aspartic acid ornithine combined with xingnaojing on the basis of routine comprehensive treatment. On the basis of conventional comprehensive treatment, 18 patients in the control group Give glutamate treatment. The clinical manifestations and blood ammonia changes in two groups were observed. [Results] The decrease of serum ammonia in the treatment group was more significant than that in the control group (P <0.05), and the markedly effective rate and total effective rate were significantly higher than those in the control group (P <0.05). [Conclusion] Aspartic acid ornithine combined with xingnaojing is effective in treating hepatic encephalopathy.